Table 2.

Associations with mortality in AIDS-KS patients

Mortality
	Unadjusted			Adjusted
	HR	95% CI	P	HR	95% CI	P
Gender
Male	1.0
Female	1.0	(0.6-1.7)	0.863	1.3	(0.7-2.2)	0.399
Age
≤35 years	1.0
>35 years	1.2	(0.7-2.0)	0.430	1.6	(0.9-2.8)	0.107
Baseline CD4 count
≤100 cells/μl	1.0
>100 cells/μl	0.5	(0.3-0.9)	0.025	0.8	(0.5-1.5)	0.556
KS Stage
T0	1.0
T1	3.5	(1.8-6.8)	<0.001	5.3	(2.7-10.6)	<0.001
S0	1.0
S1	5.7	(1.8-18-1)	0.003	5.1	(1.5-17.0)	0.008
cART
Yes	1.0
No	1.5	(0.8-2.8)	0.172	1.4	(0.7-2.8)	0.355
Chemotherapy
Yes	1.0
No	1.2	(0.7-2.2)	0.482	2.4	(1.2-4.8)	0.012
Radiation Therapy
Yes	1.0
No	1.3	(0.7-2.3)	0.398	1.1	(0.6-2.1)	0.668

KS, Kaposi's sarcoma. HR, Hazards ratio. cART, combination antiretroviral therapy